• Nenhum resultado encontrado

CD20.R22: Poliomyelitis

N/A
N/A
Protected

Academic year: 2017

Share "CD20.R22: Poliomyelitis"

Copied!
2
0
0

Texto

(1)

PAN

 

AMERICAN

 

HEALTH

 

ORGANIZATION

 

WORLD

 

HEALTH

 

ORGANIZATION

 

 

      

20th DIRECTING COUNCIL

 

23rd SESSION OF THE REGIONAL COMMITTEE

Washington D.C., 27 September – 8 October 1971

RESOLUTION

CD20.R22

POLIOMYELITIS

THE 20th DIRECTING COUNCIL,

Having considered the report of the Director on poliomyelitis vaccination programs in the countries

of Middle America and South America (Document CD20/27);1

Having heard the statement of Dr. Albert B. Sabin on the item;

Bearing in mind that poliomyelitis is a disease which affects almost all the countries of the

Americas, with varying rates of morbidity, and which periodically occurs in epidemics of varying

severity and extent;

Considering that, although poliomyelitis mortality rates are relatively low, the disease is one which

is the cause of serious sequelae;

Bearing in mind that poliomyelitis can be controlled with live attenuated oral vaccine of proven

effectiveness which is available and easy to administer and has been used successfully in several

countries of the Region, to the point of virtually eliminating in some of them the occurrence of

clinical cases; and

Considering that it is the objective of the Member Governments that poliomyelitis cease to be a

health problem in the Americas,

(2)

1. To recommend to the Member Governments that they study their own situation in order to

organize, intensify, expand or maintain, whichever is applicable, national poliomyelitis control

programs.

2. To request the Director to coordinate the studies on poliomyelitis and the development of control

programs in the Americas, and to provide the countries, within available resources, with technical

and material assistance in planning, organizing, implementing, and evaluating the corresponding

epidemiological surveillance programs.

3. To request the Director, furthermore, to provide the countries with all possible technical and

material assistance in the event of the threat or the occurrence of epidemics.

4. To authorize the Director to establish a Special Fund, in accordance with paragraph 6.7 of the

Financial Regulations of PAHO, financed by voluntary contributions, for the purpose of expanding

available assistance and undertaking poliomyelitis control programs in the Americas as indicated by

the studies and by Document CD20/27.

5. To invite Member Governments to generously contribute funds, material, and equipment for the

establishment and maintenance of the Special Fund so that the Organization may give effective and

prompt assistance to the countries in their poliomyelitis control programs.

6. To request the Director to approach the United Nations Children's Fund (UNICEF) and other

United Nations agencies or public and private institutions in order to obtain assistance for the

poliomyelitis control program.

7. To establish a sufficient reserve of live attenuated poliomyelitis oral vaccine, the cost of which is

to be borne by the Special Fund, to serve the needs for epidemic control and to be distributed to the

countries in accordance with the needs of, and progress made by, the respective programs.

8. To request the Director, in agreement with the Member Governments and utilizing the manpower

and material resources available, to take the necessary steps to promote the organization of a

regional network of laboratories for the isolation, diagnosis, and typing of poliomyelitis virus; and

to request the Member Governments of the countries in which these laboratories are established to

facilitate their use by countries that do not have such laboratories.

9. To request the Director to submit to the Directing Council a periodic report on the progress of the

program.

Sept.–Oct. 1971 OD 111, 63

Referências

Documentos relacionados

Having examined the report on the present status of leprosy programs in the Region of the Americas. (Document CD26/17), submitted by the Director in accordance with Resolution XXV

TABLE &Confirmed poliomyelitis cases among Venezuelan children vaccinated with three or less than three doses of Sabin oral vaccine, 1971. TABLE 7-Results of

and pragmatic principles of programs designed to raise the level of living of the rural population. (Document

Poliomyelitis has not been eliminated in these countries due to a number of factors, including insufficient pro- portions of the susceptible population being

Americas 1958 and 1961 by Status of Malaria Eradication ... Personnel employed in Spraying Operations in Malaria Eradication.. Programs in the Americas, 31 December 1958 and 31

Among the most important studies carried on by the Institute during its existence have been studies on: Epidemiology and pathologic anatomy of poliomyelitis;

I. SANITARY POLICE LAWS AND HEALTH MEASURES ADOPTED IN EACH COUNTRY SINCE THE FOURTH CONFERENCE. Orgalzisatioz of health services. Under the Bureau of Public

It is necessary, however, to emphasize the advantages of permanent anti-aegypti measures throughout the Americas; not the measures developed by Gorgas and Oswaldo